Area of Expertise

Fibroscan

Non-invasive liver stiffness measurement for assessing liver fibrosis and cirrhosis, essential for monitoring chronic liver disease progression.

Overview

Fibroscan (transient elastography) is a non-invasive, painless technology that measures liver stiffness to assess the degree of liver fibrosis and fatty change. It provides an alternative to liver biopsy for monitoring chronic liver disease progression.

Procedures Offered

Liver stiffness measurement (LSM)
Controlled Attenuation Parameter (CAP) for fatty liver assessment
Serial monitoring of liver fibrosis progression
Pre and post-treatment assessment
Screening for liver disease in at-risk populations

Key Benefits

1

Completely non-invasive and painless

2

Results available immediately

3

No sedation or recovery time needed

4

Can be repeated regularly for monitoring

5

Avoids risks associated with liver biopsy

6

Assesses both fibrosis and fatty liver in one test

When Is This Recommended?

  • Chronic hepatitis B or C monitoring
  • Non-alcoholic fatty liver disease (NAFLD) assessment
  • Alcoholic liver disease staging
  • Monitoring response to antiviral therapy
  • Screening in metabolic syndrome or diabetes
  • Assessment before and after lifestyle interventions
  • Cirrhosis surveillance

Schedule a Consultation

Discuss your symptoms with Dr. Banerjee to determine if this procedure is right for you.

Book Now

Contact Information

+971 58 5890431

dr.ashwinibanerjee@outlook.com

Chat with us